Importantly, viral cure enhanced the ability of high‐dose insulin infusion to suppress local SAT glycerol release (99 ± 23 vs 71 ± 25 μmol/kg/min, P < 0.05), independent of CHC genotype (Figure 4C). Here, INS is linked to cryohydrocytosis.